Morgan Stanley’s China Pharma Holdings CPHI Stock Holding History

Morgan Stanley’s Portfolio CPHI Stock Details CPHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1	Closed	–	–	7990
2021 Q3	$0	Hold	1	–	–	﹤0.01%	7945
2021 Q2	$0	Hold	1	–	–	﹤0.01%	7751
2021 Q1	$0	Buy	+1	New	+$431	﹤0.01%	7488
2014 Q1	–	Sell	-3	Closed	–	–	6478
2013 Q4	$0	Buy	+3	New	+$505	﹤0.01%	6357

Other funds holding CPHI

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

FCT

First Community Trust Dubuque, Iowa $221M AUM 48.25% 1-Year Est. Return

Morgan Stanley's CPHI Position: Q4 2021 in Review

Morgan Stanley sold out of China Pharma Holdings (CPHI) in Q4 2021, closing a stake of 1 share.

Morgan Stanley first reported a position in CPHI in Q4 2013 and held it in 4 quarters. The position peaked at $0 in Q3 2021. 7 funds tracked by Wall St. Rank hold CPHI as of Q4 2021.

Morgan Stanley reported no remaining China Pharma Holdings position as of Q4 2021 after selling out during the quarter.
Morgan Stanley sold 1 China Pharma Holdings share in Q4 2021.
Morgan Stanley first reported a position in China Pharma Holdings in Q4 2013 and held it in 4 quarters.
Morgan Stanley's China Pharma Holdings position peaked at $0 in Q3 2021.
7 funds tracked by Wall St. Rank held China Pharma Holdings as of Q4 2021.

Based on Morgan Stanley's 13F filing for Q4 2021, filed 14 Feb 2022.